Allen Akhaumere

Allen Akhaumere on Linkedin Allen Akhaumere on Facebook Allen Akhaumere on Twitter

Allen is CEO at Genodes Solutions Inc. At Peter Moss Leukemia AI Research, Allen is part of the Acute Myeloid & Lymphoblastic Leukemia AI Research, and the COVID-19 AI Research Project. Working on open-source solutions for medical research.

Allen Akhaumere
Allen Akhaumere on Linkedin Allen Akhaumere on Facebook Allen Akhaumere on Twitter

Allen Akhaumere

AI & Genomics Researcher
AI Engineer and CEO @ Genodes Solutions Inc,
Genodes Solutions Inc,

Allen started using machine learning for medical applications, when he joined Epidemium cancer research program and Challenge4Cancer four years ago. The program led to the formation of Longevity Nigeria, where Allen is currently the senior AI engineer.

As the engineer, Allen oversees the development of diabetic retinopathy detection model, genomics variant calling for long read sequencing using deep learning and assists in organizing a yearly Longevity conference. With these experiences and the desire to make precision medicine affordable and accessible to whoever needs it, Allen cofounded Genodes Solutions, where he is currently the CEO and also responsible for development of genetic guided therapy and diagnosis, using artificial intelligence.

At Peter Moss Leukemia AI Research, Allen is part of the Acute Myeloid & Lymphoblastic Leukemia AI Research, and the COVID-19 AI Research Project. Working on open-source solutions for medical research.